These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2169625)

  • 1. Biology and biochemistry of the erythropoietin receptor.
    Sawyer ST
    Prog Clin Biol Res; 1990; 352():145-52. PubMed ID: 2169625
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of the erythropoietin receptor on a Friend murine erythroleukemic cell clone, TSA8.
    Kitamura T; Tojo A; Fukamachi H; Akahane K; Saito T; Urabe A; Takaku F
    Nihon Ketsueki Gakkai Zasshi; 1988 Jul; 51(4):677-85. PubMed ID: 2849278
    [No Abstract]   [Full Text] [Related]  

  • 3. Internal autocrine regulation by erythropoietin of erythroleukemic cell proliferation.
    Stage-Marroquín B; Pech N; Goldwasser E
    Exp Hematol; 1996 Sep; 24(11):1322-6. PubMed ID: 8862443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tunicamycin modulates binding of 125I-erythropoietin to Friend erythroleukemia cells.
    Fukamachi H; Tojo A; Saito T; Kitamura T; Urabe A; Takaku F
    Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):1-6. PubMed ID: 2545067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the erythropoietin receptors of erythroleukemic cells.
    Wang FF; Wang YJ; Lee HJ; Fong JC
    Biochem Int; 1989 Jan; 18(1):163-71. PubMed ID: 2541719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
    Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
    Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin: receptors and clinical use in rheumatoid arthritis.
    Krantz SB; Sawyer ST; Sawada K; Wolfe F; Bocagno J
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():181-95; discussion 195-8. PubMed ID: 2157776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Employment of a [3H]thymidine-incorporation assay to distinguish the effects of different Friend erythroleukemia-inducing retroviruses on erythroid cell proliferation.
    Ruscetti SK
    J Natl Cancer Inst; 1986 Jul; 77(1):241-5. PubMed ID: 3459916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding and receptor-mediated endocytosis of erythropoietin in Friend virus-infected erythroid cells.
    Sawyer ST; Krantz SB; Goldwasser E
    J Biol Chem; 1987 Apr; 262(12):5554-62. PubMed ID: 3032937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of recombinant human 125I-erythropoietin to CFU-E from the spleen of anemic mice.
    Vannucchi AM; Grossi A; Rafanelli D; Vannucchi L; Rossi Ferrini P
    Haematologica; 1990; 75(1):21-6. PubMed ID: 2159943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
    Wong KS; Li YJ; Howard J; Ben-David Y
    Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of the receptor for erythropoietin in murine erythroleukemia cells after dimethyl sulfoxide treatment.
    Tojo A; Fukamachi H; Saito T; Kasuga M; Urabe A; Takaku F
    Cancer Res; 1988 Apr; 48(7):1818-22. PubMed ID: 2832053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of a new erythroid cell line.
    Yonekura S; Sytkowski AJ
    Tokai J Exp Clin Med; 1990 May; 15(2-3):189-90. PubMed ID: 1966641
    [No Abstract]   [Full Text] [Related]  

  • 14. Antipeptide antibodies as probes of the recombinant and endogenous murine erythropoietin receptors.
    Bailey SC; Feldman L; Romanowski RR; Davis KL; Sytkowski AJ
    Exp Hematol; 1993 Nov; 21(12):1535-43. PubMed ID: 7691637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four unique monoclonal antibodies to the putative receptor binding domain of erythropoietin inhibit the biological function of the hormone.
    Feldman L; Heinzerling R; Hillam RP; Chern YE; Frazier JG; Davis KL; Sytkowski AJ
    Exp Hematol; 1992 Jan; 20(1):64-8. PubMed ID: 1374344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific binding of 125I-rErythropoietin to Friend polycythemia virus-transformed erythroleukemia cells purified by centrifugal elutriation.
    Correa PN; Bard V; Axelrad AA
    Int J Cell Cloning; 1990 Jan; 8(1):39-53. PubMed ID: 2152936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common megakaryocytic and erythrocytic precursor in murine erythroleukemia (Friend) cells?
    Vannucchi AM; Paoletti F; Grossi A
    Exp Hematol; 1994 Feb; 22(2):110-1. PubMed ID: 8299731
    [No Abstract]   [Full Text] [Related]  

  • 18. Alternative splicing of the erythropoietin receptor gene correlates with erythroid differentiation in rat hematopoietic and leukemic cells.
    Fujita M; Takahashi R; Kitada K; Watanabe R; Kitazawa S; Ashoori F; Liang P; Saya H; Serikawa T; Maeda S
    Cancer Lett; 1997 Jan; 112(1):47-55. PubMed ID: 9029168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A structurally abnormal erythropoietin receptor gene in a human erythroleukemia cell line.
    Ward JC; Harris KW; Penny LA; Forget BG; Kitamura T; Winkelmann JC
    Exp Hematol; 1992 Mar; 20(3):371-3. PubMed ID: 1314735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin control of terminal erythroid differentiation: maintenance of cell viability, production of hemoglobin, and development of the erythrocyte membrane.
    Koury MJ; Bondurant MC; Atkinson JB
    Blood Cells; 1987; 13(1-2):217-26. PubMed ID: 3478108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.